Related Experiment Video
Updated: Jan 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
Yueshui Zhao1, Qijie Zhao1, Parham Jabbarzadeh Kaboli1
1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, PR China; South Sichuan Institution for Translational Medicine, Luzhou, 646000, Sichuan, PR China.
Background:
Gene expression can be posttranscriptionally regulated by a complex network of proteins. N1-methyladenosine (m1A) is a newly validated RNA modification. However, little is known about both its influence and biogenesis in tumor development.
Methods:
This study analyzed TCGA data of patients with five kinds of gastrointestinal (GI) cancers. Using data from cBioPortal, molecular features of the nine known m1A-related enzymes in GI cancers were investigated. Using a variety of bioinformatics approach, the impact of m1A regulators on its downstream signaling pathway was studied. To further confirm this regulation, the effect of m1A writer ALKBH3 knockdown was studied using RNA-seq data from published database.
Results:
Dysregulation and multiple types of genetic alteration of putative m1A-related enzymes in tumor samples were observed. The ErbB and mTOR pathways with ErbB2, mTOR, and AKT1S1 hub genes were identified as being regulated by m1A-related enzymes. The expression of both ErbB2 and AKT1S1 was decreased after m1A writer ALKBH3 knockdown. Furthermore, Gene Ontology analysis revealed that m1A downstream genes were associated with cell proliferation, and the results showed that m1A genes are reliably linked to mTOR.
Conclusion:
This study demonstrated for the first time the dysregulation of m1A regulators in GI cancer and its signaling pathways and will contribute to the understanding of RNA modification in cancer.
Insights
N1-methyladenosine (m1A) regulators are dysregulated in gastrointestinal cancers, impacting cell proliferation via the ErbB and mTOR pathways. This study reveals m1A
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Gene expression is regulated by protein networks.
- N1-methyladenosine (m1A) is an RNA modification with an unclear role in cancer.
- The biogenesis and influence of m1A in tumor development require further investigation.
Purpose of the Study:
- To investigate the role of m1A regulators in gastrointestinal (GI) cancers.
- To identify signaling pathways influenced by m1A regulators.
- To understand the impact of m1A modification on tumor development.
Main Methods:
- Analysis of TCGA data for five GI cancers.
- Investigation of m1A-related enzyme features using cBioPortal.
- Bioinformatic analysis of m1A regulator impact on downstream pathways.
- RNA-seq analysis following ALKBH3 knockdown.
Main Results:
- Observed dysregulation and genetic alterations of m1A enzymes in tumors.
- Identified ErbB and mTOR pathways, with hub genes ErbB2, mTOR, and AKT1S1, as regulated by m1A enzymes.
- Confirmed decreased expression of ErbB2 and AKT1S1 after ALKBH3 knockdown.
- Found m1A downstream genes associated with cell proliferation and linked to mTOR.
Conclusions:
- This study is the first to demonstrate m1A regulator dysregulation in GI cancer.
- The findings highlight the role of m1A regulators in GI cancer signaling pathways.
- Contributes to understanding RNA modification's role in cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Gene Regulation During Sporulation
Circadian Rhythms and Gene Regulation
Constitutive and Regulated Gene Expression
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

